FCGR2A and autoimmune thrombocytopenic purpura: Intravenous immunoglobulin (IVIG) exerts its immunomodulatory effects by blocking fragment crystallizable (Fc) gamma receptors (FcγRs), including FcγRIIa (CD32a) and FcγRIIIa (CD16a), in ITP [1–4].